NeuroSense Therapeutics (FRA:H1Z) FFO


FRA:H1Z NeuroSense Therapeutics Ltd FRA:H1Z
10 GF Score
Price €0.58
! 2 Warning Signs
View Full Analysis

What is NeuroSense Therapeutics FFO?

FFO (Funds from operations) only applies to REITs.

FRA:H1Z
10GF Score
NeuroSense Therapeutics Ltd FRA:H1Z
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NeuroSense Therapeutics Business Description

Other Exchanges NRSN:USA
Address 11 HaMenofim Street, Building B, Herzliya, ISR, 4672562
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
10GF Score

Get the complete analysis for FRA:H1Z

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.58
Price